Reproductive Health Devices are used to manage conditions related to the reproductive system, its functions and processes. The Reproductive Health Devices include Endometrial Ablation Devices, Female Sterilization Devices, Reversible Contraceptive Devices, Assisted Reproductive Technology (ART) Devices, and Postpartum Hemorrhage Control Devices. Female sterilization is a permanent intervention where the fallopian tubes are blocked using surgical and non-surgical techniques. GlobalData uses proprietary data and analytics to provide a comprehensive report on the female sterilization devices market in New Zealand. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the female sterilization devices market in New Zealand was Utah Medical Products and Gyrus ACMI.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
The fallopian tubes are blocked to prevent the sperm from fertilizing the egg, thereby preventing the woman from getting pregnant. This includes Female Sterilization Devices used in laparoscopic sterilization.
The female sterilization devices market in New Zealand can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size female sterilization devices in New Zealand, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
